Fosaprepitant Dimeglumine
Who holds supplier records for Fosaprepitant Dimeglumine? 17 organisations hold a current record for Fosaprepitant Dimeglumine: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (9), China (4), United States (1), Taiwan (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Fosaprepitant Dimeglumine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/fosaprepitant-dimeglumine
Reading the evidence
- 17 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 9 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Fosaprepitant Dimeglumine expires 11 Jan 2039. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (17)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Fosaprepitant Dimeglumine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 28992 · latest filing Mar 2015
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 31470 · latest filing Mar 2017
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 40468 · latest filing Oct 2024
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 38210, 24829 · latest filing Mar 2023
- GLAND PHARMA LTDIndia Company GMP cert on recordActive DMF 37877 · latest filing Sept 2023
- Hetero Drugs LimitedIndia Company GMP cert on recordActive DMF 25614 · latest filing Dec 2011
- LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTDChinaActive DMF 28288 · latest filing Nov 2014
- MAHI DRUGS PRIVATE LIMITEDIndiaActive DMF 38731 · latest filing Sept 2023
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 25682 · latest filing Jan 2012
- NAVINTA LLCUnited StatesActive DMF 33105 · latest filing Sept 2018
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 31484 · latest filing Mar 2017
- SCINOPHARM TAIWAN LTDTaiwanActive DMF 30973 · latest filing Jul 2017
- Shandong Anxin Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 33142 · latest filing Nov 2018
- Shandong New Time Pharmaceutical Co LtdCompany GMP cert on recordActive DMF 42341 · latest filing Aug 2025
- Viwit Pharmaceutical Co., Ltd.ChinaActive DMF 33558 · latest filing Apr 2019
- Wisdom Pharmaceutical Co., LtdChinaActive DMF 35766, 33679 · latest filing Mar 2021
- WOCKHARDT BIO AGSwitzerlandActive DMF 30137 · latest filing Dec 2015
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (13 listed products contain Fosaprepitant Dimeglumine). The latest listed patent expires 11 Jan 2039. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Fosaprepitant Dimeglumine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201782).
Chemical identity
- IUPAC name
- 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-2-phosphonato-1H-1,2,4-triazol-3-one;bis(methyl-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]azanium)
- Canonical SMILES
- C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NC(=O)N(N3)P(=O)([O-])[O-])C4=CC=C(C=C4)F.C[NH2+]C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C[NH2+]C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O
- InChIKey
- VRQHBYGYXDWZDL-OOZCZQCLSA-N
- Synonyms
- Emend, Focinvez, Fosaprepitant (as dimeglumine), Fosaprepitant dimeglumine, Fosaprepitant meglumine, Ivemend, MK-0517
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Substance P/Neurokinin-1 Receptor Antagonist
- Mechanism of action
- Cytochrome P450 2C9 Inducers; Cytochrome P450 3A4 Inducers; Cytochrome P450 3A4 Inhibitors; Neurokinin 1 Antagonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Fosaprepitant Dimeglumine?
17 organisations hold an active US FDA Type II Drug Master File or a CEP for Fosaprepitant Dimeglumine: ALIVUS LIFE SCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), Dr. Reddy's Laboratories Ltd. (India), GLAND PHARMA LTD (India), Hetero Drugs Limited (India), LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD (China) and MAHI DRUGS PRIVATE LIMITED (India), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Fosaprepitant Dimeglumine Drug Master Files are active?
ALIVUS LIFE SCIENCES LTD (DMF 28992), APITORIA PHARMA PRIVATE LTD (DMF 31470), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 40468), Dr. Reddy's Laboratories Ltd. (DMF 38210, 24829), GLAND PHARMA LTD (DMF 37877), Hetero Drugs Limited (DMF 25614), LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD (DMF 28288) and MAHI DRUGS PRIVATE LIMITED (DMF 38731) and 9 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does the FDA Orange Book list patents for products containing Fosaprepitant Dimeglumine?
Yes. The latest patent listed for an approved US product containing Fosaprepitant Dimeglumine expires 11 Jan 2039, across 13 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Fosaprepitant Dimeglumine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Fosaprepitant Dimeglumine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.